Mahmoud H. Mosli

Consultant Gastroenterologist, Assistant Professor

king abdulaziz university
Country flagSaudi Arabia

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (16)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Ulcerative colitis (UC) is a chronic autoimmune inflammatory disease that affects the colon, leading to symptoms of bloody diarrhea, abdominal cramps, and urgency. The treatment of UC has evolved over the past few decades from locally active anti-inflammatory compounds to more selective therapies that target specific arrays of the immune system. The challenge of selecting the first advanced therapy became apparent in this rapidly expanding landscape of medications. No current investigational tools, such as genetic, immunologic, or biological markers, can guide the identification of the safest and most effective therapeutic option for each patient. Hence, physicians must carefully assess patient/disease characteristics and match them with the most suitable drug through a clinically driven assessment. In this paper, we outline patient and drug characteristics that play a role in selecting first-line advanced therapies for UC and propose an algorithm for selection.

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Nahla Azzam

Associate Professor

king saud university

SAUDI ARABIA
View details

Maan Alkhattabi

Assistant Professor

king abdulaziz university

SAUDI ARABIA
View details

Yasser Bawazir

Assistant professor of Medicine and Rheumatology

king abdulaziz university

SAUDI ARABIA
View details

Nadeem Shafique Butt

Professor

king abdulaziz university

SAUDI ARABIA
View details

Doaa Anbarserry

Assistant Professor

king abdulaziz university

SAUDI ARABIA
View details